Production (Stage)
Serina Therapeutics, Inc.
SER
$5.74
-$0.1643-2.79%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -14.00K | 14.00K | 51.00K | 5.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -14.00K | 14.00K | 51.00K | 5.00K |
| Cost of Revenue | 2.95M | 2.37M | 2.42M | 1.59M | 1.11M |
| Gross Profit | -2.95M | -2.38M | -2.40M | -1.54M | -1.10M |
| SG&A Expenses | 2.91M | 1.69M | 2.91M | 2.32M | 1.22M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.86M | 4.06M | 5.33M | 3.92M | 2.33M |
| Operating Income | -5.86M | -4.07M | -5.31M | -3.87M | -2.32M |
| Income Before Tax | -4.82M | -2.75M | 1.38M | 5.18M | -15.02M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.82M | -2.75M | 1.38M | 5.18M | -15.02M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 9.00K | 12.00K | 27.00K | 27.00K | -- |
| Net Income | -4.81M | -2.74M | 1.41M | 5.20M | -15.02M |
| EBIT | -5.86M | -4.07M | -5.31M | -3.87M | -2.32M |
| EBITDA | -5.84M | -4.02M | -5.26M | -3.81M | -2.30M |
| EPS Basic | -0.49 | -0.59 | 0.16 | 0.61 | -5.38 |
| Normalized Basic EPS | -0.31 | -0.17 | 0.10 | 0.38 | -1.79 |
| EPS Diluted | -0.49 | -0.30 | 0.13 | 0.51 | -5.38 |
| Normalized Diluted EPS | -0.31 | -0.17 | 0.08 | 0.32 | -1.79 |
| Average Basic Shares Outstanding | 9.76M | 18.54M | 8.85M | 8.51M | 2.79M |
| Average Diluted Shares Outstanding | 9.76M | 18.54M | 10.75M | 10.16M | 2.79M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |